CVS - CVS Health Corp.

CVS Health: Discounted, Vertically Integrated Healthcare Winner - Richer Returns Ahead

The vertically integrated healthcare model across insurance, PBM, pharmacy, and clinical care capabilities underscores CVS Health's multi-year margin recovery prospects. This strategy has driven the better patient outcomes, superior membership retention, moderating medical benefit ratios, and robust revenue/margin expansion. Recent selloff has unlocked a cheaper P/E of 11.78x, along with the dual return prospects across capital appreciation to my LTPT of $129.90 and dividend yield of 2.84%.

Aug 23, 2026 11:42 PM • seekingalpha.com

CVS Health Stock Is Beating the Market in 2026. Here's Why Wall Street Thinks It Can Soar Another 22%.

It has added considerably to the company's fundamentals. Zooming out, CVS has crushed analyst profitability estimates lately.

Aug 22, 2026 08:45 AM • fool.com

Allworth Financial LP Invests $3.44 Million in CVS Health Corporation $CVS

Allworth Financial LP bought a new stake in CVS Health Corporation (NYSE: CVS) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 33,215 shares of the pharmacy operator's stock, valued at approximately $3,436,000. Other institutional investors have also modified their

Aug 21, 2026 11:07 PM • defenseworld.net

Mark Cuban: "No Chance" Radiologists Get Replaced by AI. He Says the Real Target Is Elsewhere

Mark Cuban says AI will never replace radiologists, and his reasoning has nothing to do with capability. The real disruption, he argues, targets a different layer of medicine entirely, one worth hundreds of billions in enterprise value at some of the biggest names in healthcare.

Aug 21, 2026 12:42 PM • 247wallst.com

B. Metzler seel. Sohn & Co. AG Buys Shares of 123,784 CVS Health Corporation $CVS

B. Metzler seel. Sohn and Co. AG acquired a new stake in CVS Health Corporation (NYSE: CVS) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 123,784 shares of the pharmacy operator's stock, valued at approximately $12,805,000. A number

Aug 21, 2026 12:19 AM • defenseworld.net

9,013,571 Shares in CVS Health Corporation $CVS Purchased by Bank of New York Mellon Corp

Bank of New York Mellon Corp purchased a new stake in CVS Health Corporation (NYSE: CVS) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,013,571 shares of the pharmacy operator's stock, valued at approximately $932,454,000.

Aug 21, 2026 12:19 AM • defenseworld.net

Asahi Life Asset Management CO. LTD. Purchases Shares of 5,630 CVS Health Corporation $CVS

Asahi Life Asset Management CO. LTD. purchased a new position in shares of CVS Health Corporation (NYSE: CVS) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 5,630 shares of the pharmacy operator's stock, valued at approximately $582,000. Other institutional investors and hedge

Aug 20, 2026 12:11 AM • defenseworld.net

AssuredPartners Investment Advisors LLC Invests $559,000 in CVS Health Corporation $CVS

AssuredPartners Investment Advisors LLC bought a new stake in CVS Health Corporation (NYSE: CVS) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 5,401 shares of the pharmacy operator's stock, valued at approximately $559,000. Several other large investors have also recently added

Aug 19, 2026 11:34 PM • defenseworld.net

3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now

Novo Nordisk, CVS Health, and Bristol Myers are top dividend stocks that are trading at modest valuations.

Aug 18, 2026 05:48 AM • fool.com

CVS Health Announces Board Changes

Teresa Heitsenrether to join the Board, bringing more than forty years of operating experience across data, analytics and technology at one of the world's largest financial institutions Larry Robbins to depart the Board after two years at CVS Health WOONSOCKET, R.I., Aug. 17, 2026 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced the appointment of Teresa Heitsenrether to its Board of Directors and departure of Larry Robbins from its Board.

Aug 17, 2026 12:15 PM • prnewswire.com

Is CVS Stock a Buy as Earnings Improve but Key Risks Remain Elevated?

CVS Health enters the second half of 2026 with stronger earnings and Aetna gains, but medical costs and Caremark risks cloud the recovery.

Aug 17, 2026 07:41 AM • zacks.com

CVS' Q2 EPS Gains From Improved Health Care Benefits Profitability

CVS Health's Q2 EPS jumps more than 40% as Health Care Benefits profitability improves, prompting a major boost to its 2026 AOI outlook.

Aug 17, 2026 07:16 AM • zacks.com

Fielder Capital Group LLC Takes $618,000 Position in CVS Health Corporation $CVS

Fielder Capital Group LLC acquired a new position in CVS Health Corporation (NYSE: CVS) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 5,972 shares of the pharmacy operator's stock, valued at approximately $618,000. Other institutional investors also recently bought

Aug 17, 2026 12:43 AM • defenseworld.net

Can CVS Sustain Its 2026 Recovery After Raising Earnings Guidance?

CVS Health is rebuilding momentum as Aetna drives stronger profits and higher 2026 guidance, but medical costs and PBM changes could test the recovery.

Aug 14, 2026 08:05 AM • zacks.com

How CVS Is Building on Its Consumer-Health Care Technology Push

CVS Health advances its $20 billion technology push with AI tools, Health100 and automation aimed at simplifying care and improving engagement.

Aug 14, 2026 07:41 AM • zacks.com

New study from CVS Caremark and Employee Benefit News shows how employers rely on their pharmacy benefit manager to create sustainable pharmacy solutions

Key opportunities include: managing GLP-1s, encouraging biosimilar substitution and employing technology to simplify and personalize the member experience WOONSOCKET, R.I., Aug. 12, 2026 /PRNewswire/ -- CVS Caremark, part of CVS Health® (NYSE: CVS), today announced the findings of a survey conducted in partnership with Employee Benefit News  that reveals why employers are increasingly relying on their pharmacy benefit manager (PBM) partners to use their expertise, scale and purchasing power to help them manage their top concern: battling rising drug prices and maintaining access to quality care.

Aug 12, 2026 05:00 AM • prnewswire.com

E. Ohman J or Asset Management AB Decreases Holdings in CVS Health Corporation $CVS

E. Ohman J or Asset Management AB lowered its position in CVS Health Corporation (NYSE: CVS) by 30.2% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,455 shares of the pharmacy operator's stock after selling

Aug 11, 2026 11:39 PM • defenseworld.net

Richard Pzena Buys LKQ Corp (LKQ) -- Shares Look 38% Undervalued on GF Value

On June 30, 2026, Richard Pzena (Trades, Portfolio)'s firm executed a significant addition to its existing position in LKQ Corp (LKQ, Financial), purchasing 9,1

Aug 11, 2026 05:03 PM • gurufocus.com

AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie leverages a strong specialty drug portfolio to offset the loss of exclusivity for its former top-selling products. CVS Health continues to expand its integrated healthcare model through its massive insurance and pharmacy network.

Aug 11, 2026 12:27 PM • fool.com

Here's Why CVS Health (CVS) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Aug 11, 2026 06:46 AM • zacks.com

CVS Health price target raised to $114 from $104 at Argus

$114.00 (was $95.58)

Argus Research

Aug 19, 2026 08:45 AM • TheFly

CVS Health price target raised to $107 from $94 at Baird

$107.00 (was $96.95)

Michael Ha · Robert W. Baird

Aug 06, 2026 09:20 AM • TheFly

CVS Health (CVS) PT Raised to $126 at UBS

$126.00 (was $99.12)

Kevin Caliendo · UBS

Aug 06, 2026 06:17 AM • StreetInsider

CVS Health price target raised to $108 from $106 at Barclays

$108.00 (was $99.12)

Barclays

Aug 06, 2026 05:15 AM • TheFly

CVS Health price target raised to $122 from $115 at UBS

$122.00 (was $107.85)

UBS

Jul 24, 2026 08:32 AM • TheFly

CVS Health price target raised to $118 from $108 at Truist

$118.00 (was $105.90)

David MacDonald · Truist Financial

Jul 14, 2026 07:49 AM • TheFly

CVS Health price target raised to $123 from $103 at Wells Fargo

$123.00 (was $104.15)

Wells Fargo

Jul 13, 2026 07:05 AM • TheFly

CVS Health price target raised to $113 from $107 at RBC Capital

$113.00 (was $104.83)

RBC Capital

Jul 09, 2026 08:12 AM • TheFly

CVS Health (CVS) PT Raised to $110 at Cantor Fitzgerald Post ChecksMember Login

$110.00 (was $102.08)

Cantor Fitzgerald

Jul 07, 2026 07:23 AM • StreetInsider

CVS Health price target raised to $103 from $85 at HSBC

$103.00 (was $102.28)

HSBC

Jul 06, 2026 10:21 AM • TheFly

CVS Health price target raised to $115 from $110 at Mizuho

$115.00 (was $95.93)

Mizuho Securities

Jun 08, 2026 07:26 AM • TheFly

CVS Health price target raised to $111 from $106 at Morgan Stanley

$111.00 (was $91.37)

Morgan Stanley

Jun 04, 2026 07:50 AM • TheFly

CVS Health price target raised to $108 from $102 at Truist

$108.00 (was $90.98)

Truist Financial

Jun 01, 2026 07:26 AM • TheFly

Piper Sandler Reiterates Overweight Rating on CVS Health (CVS)

$113.00 (was $90.98)

Jessica Tassan · Piper Sandler

Jun 01, 2026 06:54 AM • StreetInsider

CVS Health price target raised to $106 from $101 at Barclays

$106.00 (was $91.63)

Andrew Mok · Barclays

May 26, 2026 08:57 AM • TheFly

CVS Health price target raised to $110 from $102 at Mizuho

$110.00 (was $94.18)

Mizuho Securities

May 20, 2026 06:44 AM • TheFly

CVS Health price target raised to $106 from $93 at Morgan Stanley

$106.00 (was $97.85)

Morgan Stanley

May 14, 2026 08:08 AM • TheFly

CVS Health price target raised to $106 from $94 at Bernstein

$106.00 (was $95.15)

Bernstein

May 13, 2026 06:30 AM • TheFly

CVS Health price target raised to $107 from $90 at RBC Capital

$107.00 (was $86.56)

RBC Capital

May 07, 2026 09:55 AM • TheFly

CVS Health price target raised to $92 from $88 at Deutsche Bank

$92.00 (was $87.46)

Deutsche Bank

May 07, 2026 08:41 AM • TheFly